In Reply to Sari et al

Affiliations

¹ Department of Oncology, Ålesund Hospital, Møre and Romsdal Hospital Trust, Norway; Department of Clinical and Molecular Medicine, Faculty of Medicine and Health Sciences, NTNU, Norwegian University of Science and Technology, Trondheim, Norway.
² Department of Research and Innovation, Møre and Romsdal Hospital Trust, Norway; Department of Registration, Cancer Registry of Norway, Oslo, Norway.
³ Department of Clinical and Molecular Medicine, Faculty of Medicine and Health Sciences, NTNU, Norwegian University of Science and Technology, Trondheim, Norway; Cancer Clinic, St. Olavs Hospital, Trondheim University Hospital, Trondheim, Norway.
⁴ Department of Oncology, Ålesund Hospital, Møre and Romsdal Hospital Trust, Norway.
⁵ Department of Public Health and Nursing, Faculty of Medicine and Health Sciences, NTNU, Norwegian University of Science and Technology, Trondheim, Norway.
⁶ Department of Radiology, Ålesund Hospital, Møre and Romsdal Hospital Trust, Ålesund, Norway; Department of Circulation and Medical Imaging, Faculty of Medicine and Health Sciences, NTNU, Trondheim, Norway.
⁷ Department of Oncology, Oslo University Hospital, Oslo, Norway; Institute of Clinical Medicine, Faculty of Medicine, University of Oslo, Oslo, Norway.
⁸ Department of Radiation Sciences, Oncology, Umeå University, Umeå, Sweden.

Comment

Bjørg Y Aksnessæther et al. Int J Radiat Oncol Biol Phys. 2020.

. 2020 Jun 1;107(2):388-389.

doi: 10.1016/j.ijrobp.2020.02.027. Epub 2020 Feb 26.

¹ Department of Oncology, Ålesund Hospital, Møre and Romsdal Hospital Trust, Norway; Department of Clinical and Molecular Medicine, Faculty of Medicine and Health Sciences, NTNU, Norwegian University of Science and Technology, Trondheim, Norway.
² Department of Research and Innovation, Møre and Romsdal Hospital Trust, Norway; Department of Registration, Cancer Registry of Norway, Oslo, Norway.
³ Department of Clinical and Molecular Medicine, Faculty of Medicine and Health Sciences, NTNU, Norwegian University of Science and Technology, Trondheim, Norway; Cancer Clinic, St. Olavs Hospital, Trondheim University Hospital, Trondheim, Norway.
⁴ Department of Oncology, Ålesund Hospital, Møre and Romsdal Hospital Trust, Norway.
⁵ Department of Public Health and Nursing, Faculty of Medicine and Health Sciences, NTNU, Norwegian University of Science and Technology, Trondheim, Norway.
⁶ Department of Radiology, Ålesund Hospital, Møre and Romsdal Hospital Trust, Ålesund, Norway; Department of Circulation and Medical Imaging, Faculty of Medicine and Health Sciences, NTNU, Trondheim, Norway.
⁷ Department of Oncology, Oslo University Hospital, Oslo, Norway; Institute of Clinical Medicine, Faculty of Medicine, University of Oslo, Oslo, Norway.
⁸ Department of Radiation Sciences, Oncology, Umeå University, Umeå, Sweden.

No abstract available

Comment on

Second Cancers in Patients With Locally Advanced Prostate Cancer Randomized to Lifelong Endocrine Treatment With or Without Radical Radiation Therapy: Long-Term Follow-up of the Scandinavian Prostate Cancer Group-7 Trial.
Aksnessæther BY, Myklebust TÅ, Solberg A, Klepp OH, Skovlund E, Hoff SR, Fosså SD, Widmark A, Lund JÅ. Aksnessæther BY, et al. Int J Radiat Oncol Biol Phys. 2020 Mar 15;106(4):706-714. doi: 10.1016/j.ijrobp.2019.11.027. Epub 2019 Nov 28. Int J Radiat Oncol Biol Phys. 2020. PMID: 31786279 Clinical Trial.
In Regard to Aksnessætheret al.
Yuce Sari S, Elmali A, Arslan S, Ozyigit G. Yuce Sari S, et al. Int J Radiat Oncol Biol Phys. 2020 Jun 1;107(2):387-388. doi: 10.1016/j.ijrobp.2020.02.028. Epub 2020 Feb 26. Int J Radiat Oncol Biol Phys. 2020. PMID: 32112879 No abstract available.